QUEST DIAGNOSTICS INC. overview

Quest Diagnostics Introduces Testing for Oropouche Virus PR Newswire SECAUCUS, N.J., July 15, 2025 Diagnostic testing for emerging infectious disease associated with severe neurological affects SECAUCUS, N.J. , July 15, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced the launch of a new diagnostic laboratory test for the Oropouche virus, an emerging disease that is increasingly found in South and Central America and the Caribbean ....

Quest Diagnostics to Offer FDA-Cleared Fujirebio Blood Test for Alzheimer's Disease PR Newswire SECAUCUS, N.J., July 9, 2025 Test to be available for clinical and research use as soon as this summer, building on Quest's pioneering blood-based AD-Detect™ product line for assessing symptomatic patients SECAUCUS, N.J. , July 9, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, including advanced diagnostics for brain health, today announced it plans...

Quest Diagnostics Releases 2024 Corporate Responsibility Report PR Newswire SECAUCUS, N.J., June 25, 2025 SECAUCUS, N.J. , June 25, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today published its 2024 Corporate Responsibility Report . The theme of the report, Care Starts Here , reflects the pivotal role Quest plays in an individual's healthcare, providing insights from laboratory diagnostics to drive well-informed decisions. The report details...

Quest Diagnostics to Release Second Quarter 2025 Financial Results on July 22, 2025 PR Newswire SECAUCUS, N.J., June 23, 2025 SECAUCUS, N.J. , June 23, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that it will report second quarter 2025 financial results on Tuesday, July 22, 2025 , before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day....

Quest Diagnostics to Develop Multi-cancer Stratification (MCaST) Blood Test Based on MD Anderson Technology PR Newswire SECAUCUS, N.J., June 10, 2025 SECAUCUS, N.J. , June 10, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced a collaboration with The University of Texas MD Anderson Cancer Center (MD Anderson) designed to improve the assessment of elevated risk of cancer in individuals who would benefit from medically...

More Americans Know Their Streaming Platform Passwords by Heart Than Their Cholesterol Score, New Survey Reveals PR Newswire SECAUCUS, N.J., May 20, 2025 Quest's second "Know Your Health" survey explores Americans' perceptions and priorities on their well-being in 2025 Nearly one-third of Americans say their doctors/HCPs do not take the time to discuss preventive care and wellness with them; More than half of millennials, Gen Z cite barriers to accessing medical care SECAUCUS, N.J. , May 20,...

Quest Diagnostics to Speak at the William Blair 45th Annual Growth Stock Conference PR Newswire SECAUCUS, N.J., May 16, 2025 SECAUCUS, N.J. , May 16, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Jim Davis , Chairman, CEO and President, will speak on the company's strategy, performance and the latest market developments and trends during a presentation at the William Blair 45 th Annual Growth Stock Conference in...

Quest Diagnostics Declares Quarterly Cash Dividend PR Newswire SECAUCUS, N.J., May 14, 2025 SECAUCUS, N.J. , May 14, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.80 per share, payable on July 21, 2025 to shareholders of record of Quest Diagnostics common stock on July 7, 2025. About Quest Diagnostics Quest Diagnostics works across the healthcare ecosystem to...